Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024

By sjmartinez • April 10, 2025

Lewis NM, Harker EJ, Cleary S, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Halasa NB, Lauring AS, Martin ET, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Duggal A, Felzer JR, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Ferguson SAN, Mosier J, Qadir N, Chang SY, Ginde AA, Zepeski A, Mallow C, Harris ES, Johnson NJ, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Surie D, Dawood FS, Ellington S, Self WH. Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024. J Infect Dis. 2025 Apr 8:jiaf185. doi: 10.1093/infdis/jiaf185. Epub ahead of print. PMID: 40198276.

Tags: Hospitalization, Publications, Pulmonary, Critical Care & Sleep Medicine, seasonal influenza, severe influenza, vaccine effectiveness, waning

Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India

Nichols E, Kim JK, Aksman LM, Gross AL, Hu P, Kobayashi LC, Thyagarajan B, Lee J, Crimmins EM. Probing effect modification by socioeconomic status in[...]

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review

Armstrong AW, Strober BE, Liu CM, Cather JC, Merola JF, Lebwohl MG. Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a[...]

Biodistribution, shedding, and transmissibility of vusolimogene oderparepvec (RP1)

Wise-Draper TM, Robert C, Wong MK, Middleton MR, Sacco JJ, In GK, Muñoz Couselo E, Schadendorf D, Beasley GM, Niu J, Chmielowski B, Milhem MM,[...]